Blood components are the products derived from platelet-rich plasma or whole blood. Blood components like platelets, plasma, red blood cells, and white blood cells are derived from the blood by phlebotomy or hemapheresis through differential centrifugation. These blood components are isolated from whole blood in hospital laboratories and blood centers and are administered to patients suffering from several diseases through transfusion. The whole blood is usually collected and separated into major components before transfusion. Nevertheless, automated collections are becoming increasingly popular nowadays, and only blood components that are needed for transfusion are collected.
MARKET SCOPE
The "Global Blood Preparation Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Blood preparation market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Blood preparation market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product type, the global Blood preparation market is segmented into whole blood, blood derivatives, and blood components. Whole blood is segmented into rbc, plasma, platelets. Blood components is segmented into whole blood components, packed red cells, leukocyte reduced red blood cells, frozen plasma, platelet concentrate, cryoprecipitate.
- On the basis of application, the market is segmented into thrombocytosis, pulmonary embolism, renal impairment, angina blood vessel complications, others
- On the basis of end use, the market is segmented into hospitals, clinics, diagnostic centers, research labs, blood banks, pharmaceuticals, others.
MARKET DYNAMICS
Drivers:
- Rise in the demand for blood transfusion.
- Introduction of novel technologies along with the increasing usage of plasma in the pharmaceutical industry.
- Technological advancements.
Restraints:
- The risk of transmission of diseases is the major restraining factor for this market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Blood preparation market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Blood preparation market in these regions.
IMPACT OF COVID-19 ON BLOOD PREPARATION MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Coronavirus strains have been the cause of countless deaths and infections in the past. Outbreaks have been progressively more regular over the past few decades, and there is a critical need for accurate diagnostic procedures for the coronavirus. The plasma therapy, known as convalescent plasma treatment, needs blood plasma donations from people who have recuperated from Covid-19. This plasma is administered to Covid-19 patients who could not produce enough antibodies against the virus, so the plasma is required and will boost the market growth
MARKET PLAYERS
The report covers key developments in the Blood preparation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Blood preparation market are anticipated to lucrative growth opportunities in the future with the rising demand for Blood preparation in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Blood preparation market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- AstraZeneca PLC
- Sanofi S.A
- LEO Pharma A/S
- Bristol-Myers Squibb Company
- Baxter International, Inc
- Pfizer, Inc.
- Portola Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Shandong East Chemical Industry Co
- Celgene Corporation